Details for New Drug Application (NDA): 088656
✉ Email this page to a colleague
NDA 088656 describes QUIBRON-T, which is a drug marketed by Monarch Pharms and is included in two NDAs. Additional details are available on the QUIBRON-T profile page.
The generic ingredient in QUIBRON-T is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in QUIBRON-T is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 088656
| Tradename: | QUIBRON-T |
| Applicant: | Monarch Pharms |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088656
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
| Approval Date: | Aug 22, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
